SEC Form 4 · accession 0000911916-18-000147
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tony W. Collins
Officer — VP, Controller and CAO
Period of report
Jul 31, 2018
Accepted (ET)
Aug 2, 2018 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2018 | M | 2,670 | $104.01 | A | 3,146 | D | |
| Common StockF2 | Jul 31, 2018 | S | 2,670 | $125.7699 | D | 476 | D | |
| Common Stock | Jul 31, 2018 | S | 108 | $125.745 | D | 368 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $104.01 | Jul 31, 2018 | M | 2,670 | D | — | Mar 21, 2026 | Common Stock | 2,670 | 5,340 | D |
Explanation of responses
- F1Includes 138 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2018 and June 29, 2018.
- F2Represents the sale of 2,670 shares in multiple transactions ranging in price from $125.735 to $125.81 per share, resulting in a weighted average sale price of $125.7699. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F32,670 options vested on March 21, 2017; 2,670 options vested on March 21, 2018; and the remaining options will vest as to 2,670 options on each of March 21, 2019 and 2020.